Remove 2013 Remove Dosage Remove FDA
article thumbnail

Cymbalta generic availability, cost, and dosage

The Checkup by Singlecare

Food and Drug Administration (FDA) in 2004 , Cymbalta has become a widely used antidepressant to treat various mental health and pain-related conditions. The patent for brand-name Cymbalta expired in 2013, allowing other companies to produce and market duloxetine, the Cymbalta generic name. Approved by the U.S.

Dosage 52
article thumbnail

Patents: a necessary evil?

European Pharmaceutical Review

The US Food and Drug Administration (FDA) has recently expressed concern to the US PTO about some types of innovator patent strategies that potentially delay generic entry into the market. FDA highlighted that over three quarters of new patents in the Orange Book between 2005 and 2015 were assigned to existing drugs. 23 April 2013.

FDA 96
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What states use Ozempic the most?

The Checkup by Singlecare

Food and Drug Administration (FDA) recently approved Zepbound , a new version of Mounjaro, for weight loss. Studies show it can help you lose up to 10% of your body weight, depending on the dosage prescribed. It can help trigger a feeling of fullness after a meal and slow the digestion process.

Insurance 105
article thumbnail

Mounjaro vs. Ozempic: Differences, similarities, and side effects

The Checkup by Singlecare

In addition, the medications have different dosages. The dosage of Mounjaro may be increased to a maximum of 15 mg once weekly. The maximum dosage of Ozempic is 2 mg once weekly. Subcutaneous injection Subcutaneous injection What is the standard dosage? Then, the dosage is increased to 5 mg once weekly.

Dosage 52
article thumbnail

Fixed-dose combination: Considerations for design, formulation, manufacturing and analysis

Pharmaceutical Technology

Understanding both the significant competitive advantages that FDC products can offer, and the difficulties and potential pitfalls associated with development and manufacturing of FDC drugs in oral solid dosage forms is a critical first step for companies exploring this approach. Pharmaceutical companies – and the FDA – are embracing FDCs.

article thumbnail

Amarin Makes Moves towards Global Expansion of Vazkepa

Pharmaceutical Technology

In 2013, the FDA first approved Vazkepa solely for the reduction of triglyceride levels for hypertriglyceridemia. Following this, in 2019, the FDA approved Vazkepa for the reduction of cardiovascular risk. per 1,000mg dosage compared to Amarin’s $4.14 GlobalData is the parent company of Pharmaceutical Technology.

article thumbnail

Creatine side effects and how to avoid them

The Checkup by Singlecare

Common side effects of creatine Clinical studies have found no significant side effects from creatine supplementation when recommended dosages are followed, and the International Society of Sports Nutrition supports its use. Talk to a healthcare professional before resuming the supplement. Bottom line: Is creatine safe?

Dosage 94